Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 5/20 | 0.62 |
| ▸ | BRD4 | O60885 | 4/20 | 0.62 |
| ▸ | PARP1 | P09874 | 3/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | HTR1A | P08908 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4596690 | 0.82 | BRD4 (0.49) | CREBBPBRD4NFE2L2TRPA1MAOA | |
| SCHEMBL4228692 | 0.78 | BRD4 (0.43) | CREBBPBRD4NFE2L2TRPA1MAOA | |
| SCHEMBL4228696 | 0.78 | BRD4 (0.43) | CREBBPBRD4NFE2L2TRPA1MAOA | |
| SCHEMBL4230107 | 0.78 | PARP1 (0.54) | CREBBPBRD4PARP1MAOAMAOB | |
| SCHEMBL17680709 | 0.77 | CREBBP (1.00) | CREBBPBRD4 | |
| SCHEMBL6047933 | 0.70 | NFE2L2 (0.42) | CREBBPBRD4NFE2L2TRPA1MAOA | |
| SCHEMBL19122972 | 0.70 | PARP1 (0.56) | CREBBPBRD4PARP1MAOAMAOB | |
| SCHEMBL13074639 | 0.70 | PARP1 (0.56) | CREBBPBRD4PARP1MAOAMAOB | |
| SCHEMBL4596765 | 0.69 | ALDH1A1 (0.48) | CREBBPBRD4PARP1MAOAMAOB | |
| SCHEMBL6047931 | 0.69 | NFE2L2 (0.41) | CREBBPBRD4NFE2L2TRPA1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1874750-A1 | DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS | Wyeth Incoporated (US) | 2008-01-09 | — | — | EP | disclosed |